- Home
- SNN
as 05-09-2025 11:43am EST
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
| Founded: | 1856 | Country: | United Kingdom |
| Employees: | N/A | City: | N/A |
| Market Cap: | 11.4B | IPO Year: | 1999 |
| Target Price: | $27.50 | AVG Volume (30 days): | 944.4K |
| Analyst Decision: | Hold | Number of Analysts: | 3 |
| Dividend Yield: | Dividend Payout Frequency: | Semi-Annual | |
| EPS: | 0.47 | EPS Growth: | 56.15 |
| 52 Week Low/High: | $23.65 - $31.72 | Next Earning Date: | 02-25-2025 |
| Revenue: | $5,810,000,000 | Revenue Growth: | 4.70% |
| Revenue Growth (this year): | 6.39% | Revenue Growth (next year): | 5.11% |
Latest Smith & Nephew SNATS Inc. News
SNN Breaking Stock News: Dive into SNN Ticker-Specific Updates for Smart Investing
GlobeNewswire
2 days ago
Study shows patients treated with Smith+Nephew’s CARTIHEAL™ AGILI-C™ Cartilage Repair Implant have an 87% lower relative risk of Total Knee Arthroplasty or Osteotomy at 4 years¹*
GlobeNewswire
4 days ago
Smith+Nephew to showcase its CORI™ Surgical System at surgical clinics across Germany, Austria and Switzerland
Morningstar Research
8 days ago
Analyst Report: Smith & Nephew plc
GlobeNewswire
10 days ago
Nuo Therapeutics Announces Exclusive Private Label Distribution Agreement with Smith+Nephew
Zacks
10 days ago
Is Smith & Nephew SNATS (SNN) a Great Value Stock Right Now?
Zacks
10 days ago
New Strong Buy Stocks for April 29th
Simply Wall St.
14 days ago
Shareholders in Smith & Nephew (LON:SN.) are in the red if they invested five years ago
MT Newswires
15 days ago
Smith & Nephew's Q1 Results Expected to Face Analyst Caution Amid Weak Growth, China Risks, RBC Says
Compare SNN vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "SNN Smith & Nephew SNATS Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.